Publication:
The Value of Magnetic Resonance Imaging For Staging and Planning Breast-Conserving Surgery

Simple item page
dc.contributor.authorLeyla ÖZEL
dc.contributor.authorElçin ERSÖZ KÖSE
dc.contributor.authorHikmet KARAGÜLLÜ
dc.contributor.authorGökay REYHAN
dc.contributor.authorGamze KILIÇOĞLU
dc.contributor.authorPınar ATA
dc.contributor.institutionBAHÇEŞEHİR ÜNİVERSİTESİ
dc.contributor.institutionSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
dc.contributor.institutionSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
dc.contributor.institutionSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
dc.contributor.institutionSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
dc.contributor.institutionSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
dc.date.accessioned2025-09-20T20:00:26Z
dc.date.issued2019
dc.date.submitted28.02.2020
dc.description.abstractIntroduction: This study aimed to evaluate the effect of breast magnetic resonance imaging (MRI) on staging and surgicalplanning.Methods: Ninety-two females with breast cancer were enrolled in the study. We prospectively evaluated the contributionof MRI compared to mammography (MMG) and ultrasonography (USG) and impact of MRI on surgical treatment andhistopathological concordance.Results: Contribution of breast MRI to the workup and management of breast cancer in our institute was meaningful byupstaging the cases in 23/92 (25%) of the patients and suggesting a change in surgical plan in 21/92 (23%) of the patients.Surgical staging with breast MRI results correlated with the final pathological staging in 18/21 (85%) patients who had achange in surgical plan.Discussion and Conclusion: The primary therapy modality of early breast cancer is surgery. The overall tumor size, the relationshipbetween tumor size and breast size, tumor localization, tumor stage, and histopathological findings help to shapesurgical management. MRI was better than conventional diagnostic techniques in determining correct tumor diameterand in detecting non-invasive cancer areas. Consequently preoperative breast MRI is an important adjunct to conventionalimaging (USG and MMG) in the staging of breast cancer and a useful tool in treatment planning.
dc.identifier.doi10.14744/hnhj.2019.63634
dc.identifier.endpage122
dc.identifier.issn2630-5720
dc.identifier.issue2
dc.identifier.startpage116
dc.identifier.urihttps://hdl.handle.net/20.500.14719/5327
dc.identifier.volume59
dc.language.isoen
dc.relation.journalHaydarpaşa Numune Medical Journal
dc.subjectOnkoloji
dc.titleThe Value of Magnetic Resonance Imaging For Staging and Planning Breast-Conserving Surgery
dc.typeResearch Article
dcterms.references1. Kulkarni S, Singh N, Crystal P. Preoperative breast magnetic\r\nresonance imaging: applications in clinical practice. Can Assoc\r\nRadiol J 2012,63:207–14. [CrossRef ],2. Schelfout K, Van Goethem M, Kersschot E, Colpaert C,\r\nSchelfhout AM, Leyman P, et al. Contrast-enhanced MR imaging\r\nof breast lesions and effect on treatment. Eur J Surg Oncol\r\n2004,30:501–7. [CrossRef ],3. Heywang-Köbrunner SH. Contrast-enhanced magnetic resonance\r\nimaging of the breast. Invest Radiol 1994,29:94–104.,4. Gilles R, Guinebretière JM, Lucidarme O, Cluzel P, Janaud G,\r\nFinet JF, et al. Nonpalpable breast tumors: diagnosis with contrast-\r\nenhanced subtraction dynamic MR imaging. Radiology\r\n1994,191:625–31. [CrossRef ],5. Kaiser WA. MR mammography. Der Radiologe 1993,33:292–8.,6. Gilles R, Zafrani B, Guinebretière JM, Meunier M, Lucidarme\r\nO, Tardivon AA, et al. Ductal carcinoma in situ: MR imaginghistopathologic\r\ncorrelation. Radiology 1995,196:415–9.,7. Fischer U, Westerhof JP, Brinck U, Korabiowska M, Schauer A,\r\nGrabbe E. Ductal carcinoma in situ in dynamic MR-mammography\r\nat 1.5 T. [Article in German]. Rofo 1996,164:290–4.,8. Rieber A, Merkle E, Böhm W, Brambs HJ, Tomczak R. MRI of\r\nhistologically confirmed mammary carcinoma: clinical relevance\r\nof diagnostic procedures for detection of multifocal or\r\ncontralateral secondary carcinoma. J Comput Assist Tomogr\r\n1997,21:773–9. [CrossRef ],9. Fischer U, Vosshenrich R, Probst A, Burchhardt H, Grabbe E.\r\nPreoperative MR-mammography in diagnosed breast carcinoma.\r\nUseful information or useless extravagance?. [Article in\r\nGerman]. Rofo 1994,161:300–6. [CrossRef ],10. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative\r\ncontrast-enhanced MR imaging on the therapeutic\r\napproach. Radiology 1999,213:881–8. [CrossRef ],11. Lee SG, Orel SG, Woo IJ, Cruz-Jove E, Putt ME, Solin LJ, et al.\r\nMR imaging screening of the contralateral breast in patients\r\nwith newly diagnosed breast cancer: preliminary results. Radiology\r\n2003,226:773–8. [CrossRef ],12. Liberman L, Morris EA, Kim CM, Kaplan JB, Abramson AF,\r\nMenell JH, et al. MR imaging findings in the contralateral\r\nbreast of women with recently diagnosed breast cancer. AJR\r\nAm J Roentgenol 2003,180:333–41. [CrossRef ],13. Viehweg P, Rotter K, Laniado M, Lampe D, Buchmann J, Kölbl\r\nH, et al. MR imaging of the contralateral breast in patients after\r\nbreast-conserving therapy. Eur Radiol 2004,14:402–8.,14. Pediconi F, Catalano C, Padula S, Roselli A, Moriconi E, Dominelli\r\nV, et al. Contrast-enhanced magnetic resonance mammography:\r\ndoes it affect surgical decision-making in patients with\r\nbreast cancer? Breast Cancer Res Treat 2007,106:65–74.,15. Anderson DK, Billiar TR, Dunn DC, Hunter JG, Matthews JB,\r\nPollock RE. Schwartz’s Principles of Surgery. 10th ed. United\r\nStates of America: McGraw-Hill Education, 2015. p. 497–565.,16. Mumtaz H, Hall-Craggs MA, Davidson T, Walmsley K, Thurell W,\r\nKissin MW, et al. Staging of symptomatic primary breast cancer\r\nwith MR imaging. AJR Am J Roentgenol 1997,169:417–24.,17. Winchester DP, Cox JD. Standards for diagnosis and management\r\nof invasive breast carcinoma. American College of Radiology.\r\nAmerican College of Surgeons. College of American\r\nPathologists. Society of Surgical Oncology. CA Cancer J Clin\r\n1998,48:83–107. [CrossRef ],18. Ghossein NA, Alpert S, Barba J, Pressman P, Stacey P, Lorenz E,\r\net al. Breast cancer. Importance of adequate surgical excision\r\nprior to radiotherapy in the local control of breast cancer in\r\npatients treated conservatively. Arch Surg 1992,127:411–5.,19. Schmidt-Ullrich R, Wazer DE, Tercilla O, Safaii H, Marchant DJ,\r\nSmith TJ, et al. Tumor margin assessment as a guide to optimal\r\nconservation surgery and irradiation in early stage breast carcinoma.\r\nInt J Radiat Oncol Biol Phys 1989,17:733–8. [CrossRef ],20. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks\r\nJH, et al. The presence of an extensive intraductal component\r\nfollowing a limited excision correlates with prominent\r\nresidual disease in the remainder of the breast. J Clin Oncol\r\n1990,8:113–8. [CrossRef ],21. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA,\r\nTaplin SH, et al. Breast density as a predictor of mammographic\r\ndetection: comparison of interval- and screen-detected\r\ncancers. J Natl Cancer Inst 2000,92:1081–7. [CrossRef ],22. Fornage BD, Toubas O, Morel M. Clinical, mammographic, and\r\nsonographic determination of preoperative breast cancer\r\nsize. Cancer 1987,60:765–71. [CrossRef ],23. Satake H, Shimamoto K, Sawaki A, Niimi R, Ando Y, Ishiguchi T,\r\net al. Role of ultrasonography in the detection of intraductal\r\nspread of breast cancer: correlation with pathologic findings,\r\nmammography and MR imaging. Eur Radiol 2000,10:1726–32.,24. Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto\r\nA, Simonetti G, et al. Sensitivity of MRI versus mammography\r\nfor detecting foci of multifocal, multicentric breast cancer\r\nin Fatty and dense breasts using the whole-breast pathologic\r\nexamination as a gold standard. AJR Am J Roentgenol\r\n2004,183:1149–57. [CrossRef ],25. Van Goethem M, Schelfout K, Kersschot E, Colpaert C, Verslegers\r\nI, Biltjes I, et al. MR mammography is useful in the preoperative\r\nlocoregional staging of breast carcinomas with extensive\r\nintraductal component. Eur J Radiol 2007,62:273–82.,26. Boné B, Aspelin P, Bronge L, Isberg B, Perbeck L, Veress B. Sensitivity\r\nand specificity of MR mammography with histopathological\r\ncorrelation in 250 breasts. Acta Radiol 1996,37:208–13.,27. Soderstrom CE, Harms SE, Copit DS, Evans WP, Savino DA,\r\nKrakos PA, et al. Three-dimensional RODEO breast MR imaging\r\nof lesionscontaining ductal carcinoma in situ. Radiology\r\n1996,201:427–32. [CrossRef ],28. Boetes C, Mus RD, Holland R, Barentsz JO, Strijk SP, Wobbes\r\nT, et al. Breast tumors: comparative accuracy of MR imaging\r\nrelative to mammography and US for demonstrating extent.\r\nRadiology 1995,197:743–7. [CrossRef ],29. Bassett LW, Dhaliwal SG, Eradat J, Khan O, Farria DF, Brenner\r\nRJ, et al. National trends and practices in breast MRI. AJR Am J\r\nRoentgenol 2008,191:332–9. [CrossRef ],30. Oellinger H, Heins S, Sander B, Schoenegg W, Flesch U, Meiss ner R, et al. Gd-DTPA enhanced MRI of the breast: the most\r\nsensitive method for detecting multicentric carcinoma in female\r\nbreast? Eur Radiol 1993,3:223–6. [CrossRef ],31. Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble\r\nBL, et al. Staging of suspected breast cancer: effect of MR\r\nimaging and MR-guided biopsy. Radiology 1995,196:115–22.,32. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ.\r\nEffect of breast magnetic resonance imaging on the clinical\r\nmanagement of women with early-stage breast carcinoma. J\r\nClin Oncol 2002,20:3413–23. [CrossRef ],33. Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR,\r\net al. Changes in the surgical management of patients with\r\nbreast carcinoma based on preoperative magnetic resonance\r\nimaging. Cancer 2003,98:468–73. [CrossRef ],34. Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris JR.\r\nBreast relapse following primary radiation therapy for early\r\nbreast cancer. I. Classification, frequency and salvage. Int J Radiat\r\nOncol Biol Phys 1985,11:1271–6. [CrossRef ],35. Harris JR, Connolly JL, Schnitt SJ, Cady B, Love S, Osteen RT,\r\net al. The use of pathologic features in selecting the extent of\r\nsurgical resection necessary for breast cancer patients treated\r\nby primary radiation therapy. Ann Surg 1985,201:164–9.,36. Neff PT, Bear HD, Pierce CV, Grimes MM, Fleming MD, Neifeld\r\nJP, et al. Long-term results of breast conservation therapy for\r\nbreast cancer. Ann Surg 1996,223:709–16. [CrossRef ]\r\n37. Hellman S. Stopping metastases at their source. N Engl J Med\r\n1997,337:996–7. [CrossRef ],38. van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen\r\nKW, Mignolet F, et al. Prognosis after treatment for loco-regional\r\nrecurrence aftermastectomy or breast conserving therapy\r\nin two randomisedtrials (EORTC 10801 and DBCG-82TM).\r\nEORTC Breast Cancer Cooperative Group and the Danish\r\nBreast Cancer Cooperative Group. Eur J Cancer 1999,35:32–8.,39. Fischer U, Zachariae O, Baum F, von Heyden D, Funke M,\r\nLiersch T. The influence of preoperative MRI of the breasts\r\non recurrence rate in patients with breast cancer. Eur Radiol\r\n2004,14:1725–31. [CrossRef ]
dspace.entity.typePublication
local.indexed.atTRDizin

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
The Value of Magnetic Resonance Imaging For Staging and Planning Breast-Conserving Surgery.pdf
Size:
175.29 KB
Format:
Adobe Portable Document Format
Download

Collections

TR-Dizin İndeksli Yayınlar Koleksiyonu